Prognostic significance of c-KIT in vulvar cancer: bringing this molecular marker from bench to bedside

• Main Authors: de Melo Maia Beatriz, Lavorato-Rocha André, Rodrigues Iara, Baiocchi Glauco, Cestari Flávia, Stiepcich Monica, Chinen Ludmila, Carvalho Kátia C, Soares Fernando, Rocha Rafael
• Format: Article
• Language: English
• Published: BMC 2012-07-01
• Series: Journal of Translational Medicine
• Subjects: Vulvar carcinoma; HPV; c-KIT; Immunohistochemistry; qRT-PCR
• Online Access: http://www.translational-medicine.com/content/10/1/150

<p>Abstract</p> <p>Background</p> <p>Vulvar carcinomas are rare tumors, and there is limited data regarding molecular alterations. To our knowledge there are no published studies on c-KIT and squamous cell carcinomas of the vulva (VSCC). Although there are a significant number of other tumor types which express c-KIT, there remains controversy as to its relationship to patient outcome. Thus, we wished to investigate such controversial findings to determine the prognostic importance of c-KIT by evaluating its protein and mRNA expression in VSCCs, correlating these findings with clinicopathological features and Human Papillomavirus (HPV) infection.</p> <p>Methods</p> <p>c-KIT expression was scored by immunohistochemistry (IHC) as positive or negative in 139 formalin-fixed paraffin-embedded (FFPE) cases of vulvar carcinomas arrayed in a tissue microarray (TMA) using the DAKO® A4502 rabbit polyclonal c-KIT antibody (diluted 1:100). <it>c-KIT</it> mRNA was evaluated by qRT-PCR in 34 frozen samples from AC Camargo Hospital Biobank (17 tumoral and 17 non-tumoral samples) using TaqMan probes–Applied Biosystems [Hs00174029_m1]. HPV genotyping was assessed in 103 samples using Linear Array® HPV Genotyping Test kit (Roche Molecular Diagnostics, Basel, Switzerland). All results obtained were correlated with clinical and pathological data of the patients.</p> <p>Results</p> <p>c-KIT protein was positive by immunohistochemistry in 70.5% of the cases and this was associated with a higher global survival (p = 0.007), a higher recurrence-free survival (p < 0.0001), an absence of associated lesions (p = 0.001), lymph node metastasis (p = 0.0053), and HPV infection (p = 0.034). Furthermore, <it>c-KIT</it> mRNA quantitation revealed higher levels of transcripts in normal samples compared to tumor samples (p = 0,0009).</p> <p>Conclusions</p> <p>Our findings indicate that those vulvar tumors staining positively for c-KIT present better prognosis. Thus, positivity of c-KIT as evaluated by IHC may be a good predictor for use of more conservative surgery techniques and lymph node dissection in vulvar cancer. So part of the essence of our study is to see the possibility of translating our current results from the bench to the bedside. This will help provide patients a more appropriate, less mutilating treatment, in order to keep the maximum physical and psychic quality as possible to these women.</p>